PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,815.00
+60.00 (1.60%)
Last updated: Mar 12, 2026, 10:50 AM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 82.28 billion as of March 11, 2026. Its market cap has increased by 5.37% in one year.
Market Cap
82.28B
Enterprise Value
87.63B
Revenue
171.66B
Ranking
n/a
PE Ratio
698.78
Stock Price
3,815.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 82.28B, an increase of 655.44%. That is a compound annual growth rate of 6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 82.28B | -9.63% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.70T |
| Celltrion | 45.75T |
| ALTEOGEN | 19.25T |
| Sam Chun Dang Pharm. | 18.00T |
| Gencurix | 86.80B |
| BIT Computer | 85.89B |
| Oncocross | 85.37B |
| Humasis | 82.15B |